FDA Inspection 1251666 — Ewa Krecipro Nizinska
The FDA completed an inspection of Ewa Krecipro Nizinska on Aug 30, 2024 in Wroclaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 30, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wroclaw (Poland)
Additional Details
Clinical Investigator (CI)